These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1828181)

  • 21. GATA 1 mutations as clonal markers of minimal residual disease in acute megakaryoblastic leukemia of Down syndrome--a new tool with significant potential applications.
    Hitzler J; Zipursky A
    Leuk Res; 2005 Nov; 29(11):1239-40. PubMed ID: 15925405
    [No Abstract]   [Full Text] [Related]  

  • 22. Presentation of Acute Megakaryoblastic Leukemia Associated with a GATA-1 Mutation Mimicking the Eruption of Transient Myeloproliferative Disorder.
    Boos MD; Wine Lee L; Freedman JL; Novoa RA; Chu EY; Perman MJ
    Pediatr Dermatol; 2015; 32(5):e204-7. PubMed ID: 26205501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A leukemogenic twist for GATA1.
    Look AT
    Nat Genet; 2002 Sep; 32(1):83-4. PubMed ID: 12172549
    [No Abstract]   [Full Text] [Related]  

  • 24. Development of acute megakaryoblastic leukemia from a minor clone in a Down syndrome patient with clinically overt transient myeloproliferative disorder.
    Xu G; Kato K; Toki T; Takahashi Y; Terui K; Ito E
    J Pediatr Hematol Oncol; 2006 Oct; 28(10):696-8. PubMed ID: 17023834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased levels of a chromosome 21-encoded tumour invasion and metastasis factor (TIAM1) mRNA in bone marrow of Down syndrome children during the acute phase of AML(M7).
    Ives JH; Dagna-Bricarelli F; Basso G; Antonarakis SE; Jee R; Cotter F; Nizetić D
    Genes Chromosomes Cancer; 1998 Sep; 23(1):61-6. PubMed ID: 9713998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The treatment of children with acute megakaryoblastic leukemia who have Down syndrome.
    Zipusky A
    J Pediatr Hematol Oncol; 1996 Feb; 18(1):10-2. PubMed ID: 8556363
    [No Abstract]   [Full Text] [Related]  

  • 27. Myelodysplasia and acute megakaryoblastic leukemia in Down's syndrome.
    Zipursky A; Thorner P; De Harven E; Christensen H; Doyle J
    Leuk Res; 1994 Mar; 18(3):163-71. PubMed ID: 8139285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trisomy 3 as an acquired cytogenetic abnormality in primary acute megakaryoblastic leukemia.
    Azad VF; Mehrvar A; Mehrvar N
    J Cancer Res Ther; 2018 Sep; 14(Supplement):S800-S802. PubMed ID: 30249908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acute megakaryoblastic leukemia in early childhood; report of two cases].
    Morioka Y; Sugimoto T; Imashuku S; Matsumura T; Todo S; Nagai T; Koike T
    Rinsho Ketsueki; 1988 Feb; 29(2):214-20. PubMed ID: 2968473
    [No Abstract]   [Full Text] [Related]  

  • 30. The impact of trisomy 21 on early human hematopoiesis.
    Roy A; Cowan G; Vyas P; Roberts I
    Cell Cycle; 2013 Feb; 12(4):533-4. PubMed ID: 23343767
    [No Abstract]   [Full Text] [Related]  

  • 31. Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21.
    Rainis L; Bercovich D; Strehl S; Teigler-Schlegel A; Stark B; Trka J; Amariglio N; Biondi A; Muler I; Rechavi G; Kempski H; Haas OA; Izraeli S
    Blood; 2003 Aug; 102(3):981-6. PubMed ID: 12649131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leukemia and/or myeloproliferative syndrome in neonates with Down syndrome.
    Zipursky A; Brown E; Christensen H; Sutherland R; Doyle J
    Semin Perinatol; 1997 Feb; 21(1):97-101. PubMed ID: 9190039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spontaneous evolution of essential thrombocythaemia into acute megakaryoblastic leukaemia with trisomy 8, trisomy 21 and cutaneous involvement.
    Paolini R; Bonaldi L; Bianchini E; Ramazzina E; Cella G
    Eur J Haematol; 2003 Dec; 71(6):466-9. PubMed ID: 14703699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Germline GATA1s-generating mutations predispose to leukemia with acquired trisomy 21 and Down syndrome-like phenotype.
    Hasle H; Kline RM; Kjeldsen E; Nik-Abdul-Rashid NF; Bhojwani D; Verboon JM; DiTroia SP; Chao KR; Raaschou-Jensen K; Palle J; Zwaan CM; Nyvold CG; Sankaran VG; Cantor AB
    Blood; 2022 May; 139(21):3159-3165. PubMed ID: 34758059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute megakaryoblastic leukemia without GATA1 mutation after transient myeloproliferative disorder in an infant without Down syndrome.
    Inaba H; Londero M; Maurer SH; Onciu M; Ge Y; Taub JW; Rubnitz JE; Raimondi SC
    J Clin Oncol; 2011 Mar; 29(9):e230-3. PubMed ID: 21205752
    [No Abstract]   [Full Text] [Related]  

  • 36. The c-sis gene expression in cells from a patient with acute megakaryoblastic leukemia and Down's syndrome.
    Sunami S; Fuse A; Simizu B; Eguchi M; Hayashi Y; Sugita K; Nakazawa S; Okimoto Y; Sato T; Nakajima H
    Blood; 1987 Aug; 70(2):368-71. PubMed ID: 2955817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dicentric chromosome in the bone marrow of a child with megakaryoblastic leukaemia and Down's syndrome.
    Wilkie AO; Kitchen C; Oakhill A; Howell RT; Berry PJ
    J Clin Pathol; 1988 Apr; 41(4):378-80. PubMed ID: 2966817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High leukaemia cure rate in Down's syndrome explained.
    Bradbury J
    Lancet Oncol; 2005 Mar; 6(3):134. PubMed ID: 15759357
    [No Abstract]   [Full Text] [Related]  

  • 39. Favorable treatment outcome in children with acute myeloid leukemia and Down syndrome.
    Kojima S; Kato K; Matsuyama T; Yoshikawa T; Horibe K
    Blood; 1993 Jun; 81(11):3164. PubMed ID: 8499650
    [No Abstract]   [Full Text] [Related]  

  • 40. GATA1 mutations in patients with down syndrome and acute megakaryoblastic leukaemia do not always confer a good prognosis.
    Ariffin H; Garcia JC; Daud SS; Ibrahim K; Aizah N; Ong GB; Chong LA; Mohamad Z
    Pediatr Blood Cancer; 2009 Jul; 53(1):108-11. PubMed ID: 19260099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.